China Diagnostic Reagent Industry Report, 2013-2015
  • Oct./2013
  • Hard Copy
  • USD $2,200
  • Pages:81
  • Single User License
    (PDF Unprintable)       
  • USD $2,100
  • Code: ZYM049
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,300
  • Hard Copy + Single User License
  • USD $2,400
      
Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented the CAGR of over 15%, hitting RMB13.3 billion with the year-on-year growth rate of 16.7% in 2012. Moreover, the market will accelerate its pace in the wake of China’s medical reform, enhanced health awareness of people and improved physical examination technology. ?

Chinese In Vitro Diagnostic Reagent Market Size and YoY Growth Rate
20130277.png

In China, in vitro diagnostic reagents consist of biochemical diagnostic reagents, immune diagnostic reagents, molecular diagnostic reagents and hematology diagnostic reagents. Biochemical and immune diagnostic reagents enjoyed the highest 70% market share together in 2012, which was determined by the domestic medical demand. Chinese economy and the government medical expenditure stay at a low level, which affects the medical diagnosis consumption seriously.

From now to the next three years, China will desire regular tests mostly, which have the most demand for biochemical and immune diagnostic reagents. The progress in Chinese diagnosis technology and the increase of high-end consumers will boost the demand for molecular diagnostic reagents and other related reagents. The demand for biochemical and immune diagnostic reagents will occupy 60% in 2015.

By virtue of high performance-price ratio and local advantages, Chinese diagnostic reagent enterprises have broken through the monopolization of foreign brands. However, foreign companies still seize 30-40% market share in China with the technical advantages in medium- and high-end fields as well as the monopoly on “instrument + reagent” integrated platforms.

In China, there are 300-400 diagnostic reagent enterprises, including the leaders KHB, Da An Gene, Sinocare and Leadman, but their market share was still as low as 3.4%, 2.4%, 2.1% and 2.0% respectively in 2012.

The report mainly includes the followings:

20120114.gif Status quo, market segments, import and export, competition pattern and profitability of Chinese diagnostic reagent market;
20120114.gif Development trends of Chinese diagnostic reagent in terms of policies (including medical reform), population structure and detection technology;
20120114.gif Operation, diagnostic reagent business and prospect of 11 companies, such as KHB, Da An Gene, Sinocare, Leadman, BioSino Bio-technology and Science.

1 Overview of Diagnostic Reagent Industry
1.1 Definition 
1.2 Classification
1.3 Industry Chain

2 Status Quo of China Diagnostic Reagent Industry
2.1 Overview
2.2 Market Structure
2.3 Import and Export
2.3.1 Import
2.3.2 Export
2.4 Competition Pattern
2.5 Market Segments
2.5.1 Biochemical Diagnostic Reagents
2.5.2 Immunodiagnostic Reagents
2.5.3 Molecular Diagnostic Reagent
2.5.4 Comprehensive In Vitro Diagnostic Reagents
2.6 Profit Level

3 Development Forecast of China Diagnostic Reagent Industry
3.1 Overall Forecast  
3.1.1 The release of a number of favorable policies is conducive to the development of the diagnostic reagent industry
3.1.2 Large population base and enhanced aging promote the growth of the diagnostic reagent market
3.1.3 The government's medical and health expenditure keeps increasing
3.1.4 The number of outpatients maintains stable growth
3.1.5 Great Development Potentials of Detectable Items
3.1.6 Market Scale Forecast
3.2 Development Trends of Diagnostic Reagent Industry 
3.2.1 Biochemical Diagnosis and Immunodiagnosis Will Still Be the Mainstream
3.2.2 Industry Concentration Will Increase
3.2.3 Enterprises with Complete Product Line Integrating Reagents and Instruments will Win

4 Major Chinese Diagnostic Reagent Enterprises 
4.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB)
4.1.1 Profile 
4.1.2 Operation 
4.1.3 Revenue Structure 
4.1.4 Gross Margin 
4.1.5 R & D and Investment  
4.1.6 Clients 
4.1.7 In Vitro Diagnostics Business
4.1.8 Forecast and Prospect 
4.2 Da An Gene Co., Ltd.
4.2.1 Profile 
4.2.2 Operation 
4.2.3 Revenue Structure 
4.2.4 Gross Margin 
4.2.5 Clients and Suppliers 
4.2.5 R & D and Investment  
4.2.6 Diagnostic Reagent Business 
4.2.7 Forecast and Prospect 
4.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
4.3.1 Profile 
4.3.2 Operation 
4.3.3 Revenue Structure 
4.3.4 Gross Margin 
4.3.5 R & D and Investment  
4.3.6 Diagnostic Reagent Business 
4.3.7 Forecast and Prospect
4.4 BioSino Bio-technology and Science Inc.
4.4.1 Profile 
4.4.2 Operation 
4.4.4 R & D and Investment  
4.4.5 Forecast and Prospect 
4.5 Beijing Kinghawk Pharmaceutical Co., Ltd.
4.5.1 Profile 
4.5.2 Operation 
4.5.3 Revenue Structure 
4.5.4 Gross Margin 
4.5.5 Forecast and Prospect 
4.6 Livzon Pharmaceutical Group Inc.
4.6.1 Profile 
4.6.2 Operation 
4.6.3 Revenue Structure 
4.6.4 Gross Margin 
4.6.5 Diagnostic Reagent Business 
4.6.6 Forecast and Prospect 
4.7 Beijing Leadman Biochemistry Co., Ltd.
4.7.1 Profile 
4.7.2 Operation 
4.7.3 Revenue Structure 
4.7.4 Gross Margin 
4.7.5 R & D and Investment  
4.7.6 Clients 
4.7.7 Forecast and Prospect 
4.8 Changsha Sinocare Inc.
4.8.1 Profile 
4.8.2 Operation 
4.8.3 Revenue Structure 
4.8.4 Gross Margin 
4.8.5 R & D and Investment  
4.8.6 Development Forecast 
4.9 Bohui Innovation Technology Co., Ltd.
4.9.1 Profile 
4.9.2 Operation 
4.9.3 Revenue Structure 
4.9.4 Gross Margin 
4.9.5 R & D and Investment  
4.9.6 Clients 
4.9.7 Development Forecast 
4.10 Others
4.10.1 Shinva Group 
4.10.2 Humanwell Healthcare 
Major In Vitro Diagnostic Reagent Types (by Test Principle or Method)
In Vitro Diagnostic Reagent Types and Products (by National Policy)
Diagnostic Reagent Industry Chain
Revenue of China Biological Product Industry, 2005-2012
Chinese In Vitro Diagnostic Reagent Market Size, 2007-2013
Chinese In Vitro Diagnostic Reagent Market Structure, 2012
China's Diagnostic Reagent Import Volume, 2008-2013
China's Diagnostic Reagent Import Value, 2008-2013
China's Diagnostic Reagent Import Price, 2008-2013
China's Diagnostic Reagent Import Volume and Value by Country or Region, 2012-1013
China's Diagnostic Reagent Export Volume, 2008-2013
China's Diagnostic Reagent Export Value, 2008-2013
China's Diagnostic Reagent Export Price, 2007-2013
Top 10 Export Destinations of Chinese Diagnostic Reagents by Export Volume and Value, 2012-2013
Diagnostic Instrument Contrast between Domestic and Foreign Enterprises
Competition Pattern of China Diagnostic Reagent Industry
Revenue and Market Share of Some Chinese In Vitro Diagnosis Companies, 2012
IVD Gross Margin of Some Chinese Diagnostic Reagent Companies, 2008-2013
Major Policies of China Diagnostic Reagent Industry, 2010-2013
Population of 65-year-old People and Proportion in Total Population in China, 1982-2012
Two-week Prevalence Rate of People at All Ages in China
Total Medical & Health Costs and Proportion in GDP in China, 1980-2012
Chinese Medical & Health Cost Structure, 2008-2011
Number of Hospitals in China, 2005-2013
Number of Hospitals in China (by Grade), 2012
Diagnoses of Chinese Hospitals, 2005-2013
Chinese In Vitro Diagnostic Reagent Market Size, 2012-2015E
In Vitro Diagnostic Reagent Product Structure in China, 2015E
Products and Revenue of Major Global Diagnostic Reagent Companies
Development Process of Roche Diagnostics
Integrated Development Strategy of Global Leading Diagnostic Reagent Companies
KHB’s Revenue and Net Income, 2008-2013 
KHB’s Operating Revenue (by Product), 2008-2013 
KHB’s Operating Revenue (by Region), 2010-2013  
KHB’s Gross Margin (by Product), 2008-2013   
R&D Costs and % of Total Revenue of KHB, 2008-2012
KHB’s New Products, by Jul 2013 
KHB’s Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Name List and Revenue Contribution of KHB’s Top 5 Clients, 2012-2013
Name List and Procurement of KHB’s Top 5 Suppliers, 2012
KHB’s Diagnostic Reagent Revenue Structure, 2012
KHB’s Medical Instrument Types and Products, 2012
KHB’s Revenue and Net Income, 2012-2015E 
Revenue and Profit of Da An Gene, 2008-2013     
Operating Revenue of Da An Gene (by Product), 2008-2013  
Revenue Structure of Da An Gene (by Region), 2008-2013
Gross Margin of Da An Gene (by Product), 2008-2013 
Name List and Revenue Contribution of Top 5 Clients of Da An Gene, 2012-2013
Name List and Procurement of Top 5 Suppliers of Da An Gene, 2012
R&D Costs and % of Total Revenue of Da An Gene, 2010-2012
Reagent Revenue and Gross Margin of Da An Gene, 2008-2013
Instrument Revenue and Gross Margin of Da An Gene, 2008-2013
Principal Assets and Business of Da An Gene
Industrial Chain Layout of Da An Gene
Revenue and Net Income of Da An Gene, 2012-2015E 
Revenue and Net Income of Fosun Pharmaceutical, 2008-2013 
Operating Revenue of Fosun Pharmaceutical (by Product), 2008-2013
Revenue of Fosun Pharmaceutical (by Region), 2008-2013   
Gross Margin of Fosun Pharmaceutical (by Product), 2008-2013   
R&D Costs and % of Total Revenue of Fosun Pharmaceutical, 2008-2013
Revenue and Net Income of Fosun Pharmaceutical, 2012-2015E 
Revenue and Annual Profit of BioSino Bio-technology and Science, 2008-2013 
R&D Costs and % of Total Revenue of BioSino Bio-technology and Science, 2008-2013 
Revenue and Profit of BioSino Bio-technology and Science, 2012-2015E  
Revenue and Net Income of Kinghawk Pharmaceutical, 2008-2013 
Revenue of Kinghawk Pharmaceutical (by Product), 2010-2013
Gross Margin of Kinghawk Pharmaceutical (by Product), 2010-2012    
Revenue and Net Income of Kinghawk Pharmaceutical, 2012-2015E 
Livzon’s Revenue and Net Income, 2008-2012 
Livzon’s Operating Revenue (by Product), 2008-2013 
Livzon’s Revenue (by Region), 2008-2013
Livzon’s Gross Margin (by Product), 2008-2013   
Major Diagnostic Reagent Products of Livzon
Revenue and Gross Margin of Livzon’s Diagnostic Reagent and Equipment, 2008-2013
Livzon’s Revenue and Net Income, 2012-2015E 
Leadman’s Revenue and Net Income, 2008-2013 
Leadman’s Operating Revenue (by Product), 2008-2013
Leadman’s Operating Revenue (by Region), 2011-2013
Leadman’s Gross Margin (by Product), 2008-2013
R&D Costs and % of Total Revenue of Leadman, 2008-2013
Leadman’s Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
Name List and Revenue Contribution of Leadman’s Top 5 Clients, 2012-2013 
Number of Leadman’s Dealers, 2008-2012   
Leadman’s Revenue and Net Income, 2012-2015E 
Sinocare’s Revenue and Net Income, 2009-2013 
Sinocare’s Capacity, Output and Sales Volume, 2009-2011 
Sinocare’s Blood Sugar Testing Instrument and Strip Sales Price (by Type), 2009-2011
Sinocare’s Operating Revenue (by Product), 2009-2013 
Sinocare’s Revenue (by Region), 2009-2013       
Sinocare’s Gross Margin (by Product), 2009-2011
R&D Costs and % of Total Revenue of Sinocare, 2010-2013
Revenue and Net Income of Sinocare, 2012-2015E 
Revenue and Net Income of Bohui Innovation, 2010-2013 
Output, Sales Volume and Inventory of Bohui Innovation, 2011-2012
Revenue of Bohui Innovation (by Product), 2010-2013 
Gross Margin of Bohui Innovation (by Product), 2010-2013 
R&D Costs and % of Total Revenue of Bohui Innovation, 2010-2013
Fund-raising Projects and Capacity of Bohui Innovation  
Name List, Revenue Breakdown and Percentage of Clients of Bohui Innovation, 2012-2013 
Revenue and Net Income of Bohui Innovation, 2012-2015E      
Revenue and Net Income of Shinva, 2008-2012 
Revenue and Profit of Humanwell Healthcare, 2007-2013   

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统